Regulatory
Matters |
|
Antipsychotic
drugs |
|
Belatacept |
|
Dexrazoxane |
|
Epoetin
alfa and Darbepoetin alfa |
|
Finasteride
and Dutasteride |
|
H1N1
influenza vaccine (Pandemrix) |
|
Leflunomide |
|
Linezolid |
|
Methylene
blue |
|
Metoclopramide |
|
Nimesulide |
|
Paracetamol |
|
Pioglitazone |
|
Simvastatin |
|
Simvastatin
and Atorvastatin |
|
Tamoxifen |
|
Thalidomide |
|
Valproate
sodium, divalproex sodium, valproic acid |
|
Varenicline |
Safety of Medicines |
|
Amiodarone |
|
Clozapine |
|
Dronedarone |
|
Drospirenone-containing
combined oral contraceptives |
|
Liraglutide
[rDNA origin] Injection |
|
Rituximab |
|
Risperidone
and Ropinirole |
Feature |
|
Kenya
hosts two pharmacovigilance training courses |